Compare HOUR & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOUR | ESLA |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.4M | 69.5M |
| IPO Year | 2021 | N/A |
| Metric | HOUR | ESLA |
|---|---|---|
| Price | $2.40 | $1.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 142.2K | 37.1K |
| Earning Date | 05-13-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 150.00 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $142,440,236.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $47.40 | ★ N/A |
| Revenue Growth | ★ 3.03 | N/A |
| 52 Week Low | $1.18 | $0.78 |
| 52 Week High | $6.84 | $3.15 |
| Indicator | HOUR | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 56.99 | 38.04 |
| Support Level | $1.80 | $1.15 |
| Resistance Level | $2.61 | $1.35 |
| Average True Range (ATR) | 0.30 | 0.14 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 40.46 | 0.81 |
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.